DCIS ( Ductal Carcinoma in Situ )

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

Uncertainties in the management of screen-detected ductal carcinoma in situ
Uncertainties in the management of screen-detected ductal carcinoma in situ


One in every thousand women who attend for breast screening is diagnosed with DCIS. This is when the breast cancer cells are completely contained within the breast ducts and have not spread into the surrounding breast tissue. DCIS may also be referred to as non-invasive or intraductal cancer. Most women with DCIS have no signs or symptoms so it is mostly found through breast screening.

The DCIS usually shows up on a mammogram as an area in which calcium has been deposited in the milk ducts (known as microcalcification). A small number of women with DCIS may have symptoms such as a breast lump or discharge from the nipple.

It is important to remember that DCIS is not harmful at this stage, but if it is left untreated it may, over a period of years, begin to spread into (invade) the breast tissue surrounding the milk ducts. It is then known as invasive breast cancer.

Some areas of DCIS will never develop into invasive breast cancer even with no treatment. However, treatment is usually given for DCIS because it is not currently possible to tell which areas will definitely develop into an invasive cancer.

Treatment of DCIS

The treatment almost always cures DCIS. If you have DCIS you will be referred to a breast surgeon or cancer specialist (oncologist). It is important to discuss with them the benefits and possible side effects of any treatment in your particular case.

The treatments offered for DCIS are removal: usually as a lumpectomy (removal of the area of DCIS and some surrounding healthy tissue), but sometimes by mastectomy (removal of the whole breast) if several areas are affected or if the area is large and high-grade. The surgery may be followed by radiotherapy or hormonal therapy.

The NHS Breast Screening Programme is funding The Sloane Project, to improve the quality of care for women with screen-detected DCIS and other non-invasive breast cancers and atypical hyperplasias.

Search this site for:

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/dcis.html
site created by The Net Effect
©NHS Cancer Screening Programmes